Company / Revenue per Share
Moderna Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$5.04
FY2025
5-year range
$0.15 / $17.79
FY2021-FY2025
Trend
-40.5%
vs FY2024
Sector context
#65 of 154
Health Care
What the data says
At $5.04, Moderna's revenue per share ranks #65 of 154 in the Health Care sector. Revenue per Share has fluctuated over the past 10 years, ranging from $0.15 in FY2021 to $17.79 in FY2023.
Based on SEC 10-K filings.
5.04 in FY2025 with a 5-year CAGR of +16.1%.
Declined from $17.79 to $5.04 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +36.2%
- 5-Year CAGR
- +16.1%
- 10-Year CAGR
- -
Sector benchmark
#65 of 154 in Health CareTop 42% of 154This company $5.04 Sector average $15.09
▼
-66.6% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 40.5% year-over-year.
- Ranks #65 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2023.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.04 | -40.5% |
| FY2024 | $8.47 | -52.4% |
| FY2023 | $17.79 | +792.7% |
| FY2022 | $1.99 | +1225.0% |
| FY2021 | $0.15 | -93.7% |
| FY2020 | $2.39 | +1207.6% |
| FY2019 | $0.18 | -91.2% |
| FY2018 | $2.07 | -35.1% |
| FY2017 | $3.19 | +78.8% |
| FY2016 | $1.78 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026